Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
383.42
374.98
402.15
375.37
484.25
434.16
434.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
383.42
374.98
402.15
375.37
484.25
434.16
434.15
Raw Material Cost
104.65
91.93
101.61
112.87
145.17
139.39
168.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.22
1.91
3.33
5.40
9.59
14.70
15.85
Selling and Distribution Expenses
206.68
212.16
217.91
203.49
230.33
224.99
278.60
Other Expenses
3.35
2.98
3.72
3.52
3.16
1.12
4.27
Total Expenditure (Excl Depreciation)
349.07
335.76
360.05
356.96
416.64
390.27
505.98
Operating Profit (PBDIT) excl Other Income
34.4
39.2
42.1
18.400000000000002
67.6
43.9
-71.8
Other Income
0.31
10.62
3.12
26.33
32.60
23.91
20.94
Operating Profit (PBDIT)
55.79
73.64
73.95
13.57
146.35
97.77
-11.79
Interest
4.22
1.91
3.33
5.40
9.59
14.70
15.85
Exceptional Items
0.08
-16.56
-3.09
-248.32
-0.19
-0.04
-406.80
Gross Profit (PBDT)
278.77
283.05
300.54
262.50
339.08
294.77
265.27
Depreciation
26.16
27.87
34.97
41.14
49.83
35.01
42.66
Profit Before Tax
25.49
27.31
32.57
-281.29
86.74
48.02
-477.10
Tax
12.49
11.41
11.02
35.06
31.32
3.52
5.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
24.35
27.42
31.01
-307.82
73.69
46.59
-465.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
24.35
27.42
31.01
-307.82
73.69
46.59
-465.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-9.56
-10.81
-9.93
-19.81
-22.95
-5.23
-25.42
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.79
16.61
21.07
-327.64
50.74
41.36
-490.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
570.07
542.36
520.59
485.34
783.92
730.27
711.41
Earnings per share (EPS)
0.09
0.1
0.12
-1.16
0.28
0.18
-1.75
Diluted Earnings per share
0.09
0.1
0.12
-1.16
0.28
0.18
-1.75
Operating Profit Margin (Excl OI)
7.65%
9.38%
8.92%
-14.36%
13.2%
8.95%
-17.37%
Gross Profit Margin
13.47%
14.71%
16.79%
-63.98%
28.2%
19.12%
-100.07%
PAT Margin
6.35%
7.31%
7.71%
-82.01%
15.22%
10.73%
-107.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 2.24% vs -6.76% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -10.84% vs -21.33% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -11.90% vs -11.02% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 121.05% vs -42.42% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Guanhao Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
383.42
0
383.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
383.42
0
383.42
Raw Material Cost
104.65
0
104.65
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.22
0
4.22
Selling and Distribution Expenses
206.68
0
206.68
Other Expenses
3.35
0.00
3.35
Total Expenditure (Excl Depreciation)
349.07
0
349.07
Operating Profit (PBDIT) excl Other Income
34.35
0.00
34.35
Other Income
0.31
0
0.31
Operating Profit (PBDIT)
55.79
0
55.79
Interest
4.22
0
4.22
Exceptional Items
0.08
0
0.08
Gross Profit (PBDT)
278.77
0
278.77
Depreciation
26.16
0
26.16
Profit Before Tax
25.49
0
25.49
Tax
12.49
0
12.49
Provisions and contingencies
0
0
0.00
Profit After Tax
24.35
0
24.35
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
24.35
0
24.35
Share in Profit of Associates
0
0
0.00
Minority Interest
-9.56
0
-9.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.79
0
14.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
570.07
0
570.07
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
7.65%
0%
0.00
7.65%
Gross Profit Margin
13.47%
0%
0.00
13.47%
PAT Margin
6.35%
0%
0.00
6.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 38.34 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 2.24% vs -6.76% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1.48 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -10.84% vs -21.33% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.55 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.90% vs -11.02% in Dec 2024
Annual - Interest
Interest 0.42 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 121.05% vs -42.42% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.65%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






